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Abstract A fast-track clinical pathway is designed to
streamline patient care delivery and maximize cost effec-
tiveness. It has decreased postoperative length of stay
(LOS) and hospital charges for many surgical procedures.
However, data on clinical pathways after liver surgery are
sparse. This study examined whether use of a fast-track
clinical pathway for patients undergoing elective liver
resection affected postoperative LOS and hospital charges.
A fast-track clinical pathway was developed and imple-
mented by a multidisciplinary team for patients undergoing
liver resection. Between July, 2007 and May, 2008, a total
of 117 patients underwent elective liver resection: the fast-
track clinical pathway (education of patients and families,
earlier oral feeding, earlier discontinuation of intravenous
fluid, no drains or nasogastric tubes, early ambulation, use
of a urinary catheter for less than 24 h and planned dis-
charge 6 days after surgery) was studied prospectively in
56 patients (postpathway group). These patients were
compared with the remainder who had usual care (pre-
pathway group). Outcome measures were postoperative
LOS, perioperative hospital charges, intraoperative and
postoperative complications, mortality, and readmission
rate. Among all patients, 69 (59%) had complicating dis-
eases and/or a history of surgery and 24 patients belonged
to American Society of Anesthesiologists grade III–IV.
Compared with the prepathway group, the postpathway
group had a significantly shorter postoperative LOS (7 vs.
11 days, P \ 0.01). The average perioperative hospital
charges were RMB 26,626 for patients in the prepathway
group and only RMB 21,004 for those in the postpathway
group (P \ 0.05), with no differences in intraoperative
and postoperative complications (P = 0.814), mortality
(P = 0.606), and readmission rate (P = 0.424). Imple-
mentation of the fast-track clinical pathway is an effective
and safe method for reducing postoperative LOS and
hospital charges for high-risk patients undergoing elective
liver resection. The result supports the further development
of fast-track clinical pathways for liver surgical
procedures.
Keywords Liver resection  Clinical pathway 
Perioperative care
Introduction
A fast-track clinical pathway consists of optimal sequenc-
ing and timing of interventions by physicians, nurses, and
other staff for a particular diagnosis or procedure [1]. It was
originally adapted from engineering fields, where it was
used to increase efficiency and provide a timeline for job
completion. A fast-track clinical pathway is developed and
implemented by a multidisciplinary team to streamline
patient care delivery and maximize effectiveness while
minimizing cost. Contemporary socioeconomic pressures
for more cost-efficient delivery of medical care are strong
motivating forces for the development of a fast-track
clinical pathway. To date, some studies have found that the
fast-track clinical pathways can lead to a decrease in
postoperative length of stay (LOS) and hospital charges,
such as in colorectal [2, 3], vascular [4, 5], obstetric [6],
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urologic [7, 8], and pediatric procedures [9]. However, its
role in hepatic surgery is still controversial.
Liver resection is a common abdominal operation with
high risk of postoperative morbidity and mortality [10–13].
Data on the implementation of a fast-track clinical pathway
in liver surgery are sparse [14, 15]. We hypothesized that
such a fast-track clinical pathway for patients undergoing
elective liver resection could help decrease postoperative
LOS and hospital charges without increasing intraoperative




Between July 2007 and May 2008, a total of 117 patients
underwent elective liver resection in a teaching hospital of
a medical university with a high-volume hepatic surgery
unit. The fast-track clinical pathway was introduced by a
multidisciplinary team to serve the patients on 1 January
2008. Fifty-six patients were treated according to the fast-
track clinical pathway (postpathway group) and were
compared with the 61 patients who had been treated
according to the previous traditional pathway (prepathway
group). Before surgery, all patients received antithrom-
botic prophylaxis subcutaneously and were given intra-
venous antibiotics. Liver resection was performed by the
same liver surgeons in both groups. The patients had an
extended right subcostal incision or bilateral subcostal
incision, and the types of liver resection, according to the
Brisbane 2000 terminology [16], are shown in Table 1.
Following the operation, patients were not sent routinely
to the intensive care unit (ICU) but were monitored
overnight in the recovery room and then transferred to the
ward, provided they were clinically stable. Patients with
both malignant and benign disease were included in this
analysis and excluded if they underwent hepaticojejunos-
tomy, or choledochotomy and placement of a T-tube
simultaneously.
Clinical Pathway
The multidisciplinary team that developed the fast-track
clinical pathway included surgeons, nursing staff, physical
therapists, and operating room personnel. All aspects of
patient care were analyzed to streamline interventions for
fast tracking, including the preoperative evaluation, edu-
cation of patients and families, earlier oral feeding, earlier
discontinuation of intravenous fluid, no drains or naso-
gastric tubes, early ambulation, use of a urinary catheter for
less than 24 h and planned discharge 6 days after surgery,
and were outlined for each day (Table 2). Epidural anal-
gesia had been performed routinely in the authors’
department since 2001, and no modification of the epidural
regimen was introduced during the study period.
The fast-track clinical pathway was implemented for the
patients at the time a decision was made for surgery. The
preoperative evaluation was performed the day before
surgery and included medical history, physical examina-
tion, and imaging studies, including abdominal ultrasound,
computed tomography, magnetic resonance cholangiopan-
creatography, and triphasic liver computed tomography
scan, blood analysis (complete blood count with platelets,
electrolyte, serum creatinine, coagulation studies, and liver
function tests), and an anesthesiology consultation. The
preoperative education of patients and families was then
conducted using a patient-friendly version of the clinical
pathway to help them to understand general pathway goals
and expectations. Intravenous fluid was administrated
during the operation and discontinued on postoperative day
3 unless there was a medical reason to do otherwise,
compared with discontinuation on day 5 in the previous
traditional pathway. Patients were actively encouraged to
exercise on bed 6 h after the operation and stand or walk
out of bed at least 2 h on day 1 after surgery and gradually
increase the workout. However, in the traditional pathway
patients had to stay in bed 2–3 days after the operation.
Oral intake of fluids was started after 6 h postoperatively,
aiming for at least 600 ml of oral intake on the day of
surgery. Preprinted discharge instructions were distributed
to allow time for patients and their families to review and
Table 1 Types of liver
resection
* v2 test, except  Fisher’s exact
test
Prepathway n = 61
n (%)
Postpathway n = 56
n (%)
P*
Non-anatomical resection 9(14.8) 7(12.5) 0.723
Segmentectomy 14(23.0) 13(23.2) 0.973
Bisegmentectomy 17(27.9) 17(30.4) 0.767
Hemihepatectomy 11(18.0) 9(16.1) 0.778
Extended hemihepatectomy 5(8.2) 4(7.1) 1.000
Centralresection/trisegmentectomy 5(8.2) 6(10.7) 0.641
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formulate questions before discharge on postoperative day
5. Arrangements for discharge were made on postoperative
days 6, provided that all organ functions had returned to
normal and pain could be managed with oral analgesics.
The patients were seen in the outpatient clinic for removal
of stitches and information about histology on days 10 and
15, and a final postoperative checkup was scheduled on day
30 (Table 2).
Outcomes
Data were obtained from retrospective chart reviews for
patients treated before implementation of the clinical
pathway and from a prospective clinical database for
patients treated after implementation. About 1 month after
the patient was discharged from hospital, the administration
center provided the individual’s perioperative charges,
postoperative LOS, complications, mortality, and readmis-
sion data. Outcome measures were postoperative compli-
cations (in-hospital and within 30 days of discharge),
mortality (in-hospital death, irrespective of duration of stay,
or death occurring within 30 days of discharge), average
postoperative LOS (including readmission), readmission
rate (within 30 days of discharge), and average periopera-
tive hospital charges. Complications were classified as
general and surgical complications. General complications
included pneumonia, wound infection, urinary tract infec-
tion, delayed gastric emptying, postoperative ileus (defined
as abdominal distension, colicky pain, absence of passage
of flatus, and nausea/vomiting), deep venous thrombosis/
pulmonary embolism, myocardial infarction, renal fail-
ure, and liver failure. Surgical complications included
the following events requiring intervention/reoperation:
bile leak with sepsis, upper gastrointestinal bleeding,
Table 2 Fast-track critical
pathway for liver resection
NSAID non-steroidal anti-
inflammatory drug
Before surgery Preoperative evaluation
Education of patients and families
No preanaesthetic medication
No bowel preparation
Day of surgery Carbohydrate drinks up to 2 h before surgery
Placement of thoracic epidural catheter (T7–T9 level) with continuous
infusion of bupivacaine 0.125% with fentanyl l–2 lg/ml at a rate
of 4–6 ml/h until day 3, plus intravenous paracetamol or NSAIDs
No routine nasogastric drainage and drainage of the peritoneal cavity
No sent routinely to the intensive care unit
Physical therapy twice
Restart oral feeding of liquid diet 6 h after surgery
Postoperative day 1 Out of bed ambulation, mobilized \2 h
Physical therapy four times per day
Reduction of intravenous fluids
Patient drinks at least 1.0 l liquid diet
Urinary bladder catheter in the morning
Postoperative day 2 Mobilization four times a day, \4 h
Patient drinks at least 1.5 l liquid diet
Reduction of intravenous fluids
Postoperative day 3 Mobilization four times a day, \6 h
Patient drinks at least 2.0 l light diet
Continuous reduction of intravenous fluids
Epidural catheter removed in the morning, NSAIDs started or continue
Postoperative day 4 Switch all medications to oral route
Discontinuation of intravenous fluids
Semiliquid diet of at least 1.5 l
Mobilization of four times per day, [6 h
Postoperative day 5 Mobilization a minimum of four times per day, [6 h
Normal oral intake
Distribute preprinted discharge instructions
Postoperative day 6 Full mobilization
Discharge home
Outpatient appointment made on postoperative day 10, 15, and 30
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intra-abdominal abscess, a large quantity of pleural effu-
sion, and fascial dehiscence. The severity of complications
was according to a validated complication classification
[17]. Postoperative LOS was determined by calculating the
difference in calendar days between the day of the operation
and discharge, including readmissions. The total perioper-
ative hospital charges were categorized into four categories,
included charges for operation and anesthesia, auxiliary
examination (including laboratory and radiology), drugs,
and other.
Statistical Analysis
Results were analyzed using SPSS version 16.0 for Win-
dows (SPSS, Chicago, IL, USA). For discrete variables,
absolute and relative frequencies are given. For other
variables, median values and range are presented. LOS and
perioperative hospital charges were analyzed using the
Mann–Whitney U test. Morbidity and mortality rates were
analyzed using the v2 test or Fisher’s exact test. Differences
were considered significant at P = 0.05 or less.
Results
Clinical data are shown in Table 3, and there were no sta-
tistically significant differences between the two groups,
including duration of surgery and operation blood loss. In
this study, it is important to note that the patients consisted of
high-risk groups with lower than normal body mass index,
69 patients having complicating diseases and/or a history of
surgery, and 24 patients belonging to American Society of
Anesthesiologists (ASA) grade III–IV. Some 50 patients had
co-morbidities, and the main complicating diseases were
cholangitis as a result of cholelithiasis which is especially
prevalent in the southeast coast of China. Only 48 patients
had no complicating disease nor a history of surgery.
The fast-track clinical pathways were generally well
tolerated. Two patients in the postpathway group and one
patient in the prepathway group developed postoperative
ileus and required insertion of a nasogastric tube, and this
was resolved within 4, 5, or 7 days by restricting intake. One
patient in the postpathway group had an intra-abdominal
drain inserted because of bile leak with sepsis, and one
patient in the prepathway group had an intra-abdominal
drain because of an intra-abdominal abscess. One patient in
the prepathway group required insertion of a closed thoracic
drainage tube as a result of a large quantity of pleural effu-
sion. Three patients had signs of intra-abdominal bleeding,
and diagnostic laparoscopies demonstrated intra-abdominal
haematoma with active bleeding in two patients and
requiring reoperation for hemostasis (one in each group),
while the third patient, in the prepathway group, showed
intra-abdominal haematoma without any obvious source of
active bleeding and was treated conservatively treatment
under close observation. Eleven of 56 patients in the post-
pathway group (20%) were sent to the ICU, significantly
fewer than in the prepathway group (87%) (P \ 0.001).
A common criticism of a fast-track clinical pathways is
the potential for a negative impact on patient care. We
Table 3 Demographics and
perioperative factors of patients
undergoing liver resection in
both groups
ASA American Society of
Anesthesiologists
Values are median (interquartile
range)
* v2 test, except  Fisher’s exact
test
Prepathway n = 61 Postpathway n = 56 P*
Age (years) 55(22–81) 57(23–73) 0.194
Sex ratio (M:F) 34:27 31:25 0.967
Body mass index 18(14–27) 17(14–28) 0.379
ASA 0.690




Treated for cholangitis 13 11 0.469
Treated for pancreatitis 5 4 0.723
Treated for diabetes mellitus 3 3 0.719
Treated for pulmonary disease 4 2 1.000
Treated for liver abscess 2 2 1.000
Treated for cardiovascular disease 1 0 1.000
History of surgery 11 10 0.649
Median duration of surgery (m) 125 (81–187) 110(60–160) 0.451
Median operative blood loss (ml) 850 (0–2300) 760 (0–2100) 0.558
No. of patients transfused 25 21 0.659
Median volume transfused (ml) 600(200–1800) 550(400–1600) 0.410
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attempted to assess possible increases in complications,
especially in the associated areas. However, there was no
statistically significant difference in our measures of mor-
bidity and mortality between the two groups. Using a
standard classification of complications by severity, there
was also no a trend toward more severe complications in the
postpathway group compared with the prepathway group
(Table 4). One patient died in the postpathway group (a
result of liver failure following an extended right hepatec-
tomy in unsuspected alcoholic liver disease with death on
day 20) and one patient in the prepathway group (myocar-
dial infarction and cardiovascular failure with death on day
2). No significant difference in the re-admission rate (four in
the postpathway group vs. 2 in the prepathway group) was
observed between the groups in the 30 days after surgery.
Four patients were readmitted for a median of 9 days (range
1–25 days) in the postpathway group, one for wound
infection (6 days), one for deep vein thrombosis (4 days),
one for intra-abdominal bleeding (6 days), and one for bile
leak with sepsis (25 days). In the prepathway group, two
patients were readmitted for 5 and 21 days, one for wound
rupture and one for intra-abdominal abscess.
Data concerning postoperative LOS are presented in
Fig. 1 and show that postoperative LOS was significantly
shortened by implementation of the fast-track clinical
pathway. Before implementation, the median postoperative
LOS was 11 (range 4–37) days. Implementation of the
pathway resulted in a reduction of LOS to 7 (range 3–26)
days (P \ 0.01). Perioperative hospital charges are pre-
sented in Fig. 2. The mean charges per perioperative hos-
pital stay were RMB 21,004 for the postpathway group
significantly less than the RMB 26,626 for the prepathway
group (P \ 0.05). The distribution of perioperative hospital
charges in the four categories was analyzed, including sur-
gery and anesthesia, drugs, auxiliary examination, and other.
The charges for other items decreased more significantly in
the postpathway group as compared to the prepathway group
(P \ 0.01), and there were also significant decrease in drugs
(P \ 0.05) and auxiliary examinations (P \ 0.05), but no
difference for surgery and anesthesia (P = 0.550).
Discussion
We developed and implemented a fast-track clinical path-
way by a multidisciplinary team to detail and direct opti-
mal daily treatment and recovery goals for patients
undergoing hepatic liver resection. Our goal in developing
a high-quality, cost-effective health care for these patients
was to eliminate unnecessary expenses while continuing to
provide treatments or services considered important or
Table 4 Postoperative course
in patients undergoing liver
resection in both groups
* v2 test, except  Fisher’s exact
test
a More than one complication
was counted per patient
b Severity of complications
classification (17), counting the
severest complication per
patient
Prepathway n = 61
n (%)
Postpathway n = 56
n (%)
P*
Total complicationsa 27(44.3) 26(46.4) 0.814
General complications 21 15 0.371
Surgical complications 6 11 0.133
Patients with a complicationb 23(37.7) 21(37.5) 0.982
Grade I 11 8
Grade II 9 10
Grade IIIa 1 1
Grade IIIb 0 1
Grade IVa 1 0
Grade IVb 0 0
Grade V 1 1
Mortality 1(1.6) 1(1.8) 0.706
Readmissions 2(3.3) 4(7.1) 0.424
Fig. 1 Total postoperative length of hospital stay including readmis-
sions, in the postpathway group and the prepathway group. Horizontal
lines within boxes, boxes, and error bars represent median, interquartile
range, and total range, respectively. P \ 0.01 (Mann–Whitney U test)
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essential, and to achieve an optimal outcome. In the current
study, we confirmed that implementation of the clinical
pathway significantly decreased postoperative LOS and
perioperative hospital charges. More importantly, the
decrease in LOS and charges was not achieved at the
expense of increased postoperative complications or read-
mission rates in the postpathway group.
Perioperative intervention improvements that can be
linked to pathway implementation are concerned with
postoperative LOS. Multiple factors contributed to the
reduction in LOS, including altering patients’ expectations,
preoperative education of hospital health-care providers,
earlier mobilization and return of normal oral intake, and
earlier discontinuation of intravenous fluid. Although
average postoperative LOS (including readmissions) was
reduced significantly from 11 to 7 days, the LOS was
longer than others reported in the literature [14, 15]. The
main reason was the high-risk nature of the patients in our
study: among the 117 patients studied, more than half had
complicating diseases and/or a history of surgery, and one-
fifth belonged to ASA III–IV. Van Dam et al. reported that
among 161 patients where median LOS was reduced to
6 days on implementation of multimodal enhanced recov-
ery after surgery, only 30 belonged to ASA III, and none
had a history of surgery [15]. Another study reported that
median LOS was 4 days when a ‘‘fast-track’’ protocol was
employed, but only one patient belonged to ASA III [14].
The reduction in length of postoperative hospital stay
correlated directly with a significant reduction in total
hospital charges [2, 18].
Perioperative hospital charges decreased significantly
after implementation of the fast-track clinical pathway.
These savings were achieved by fulfilling the pathway
goals of reducing the variations in the fast-track clinical
pathway and optimizing resource utilization. Analysis of
the cost data by delivery system illustrated that the savings
occurred in all components and resulted from an aggrega-
tion of multiple small cost-saving strategies, including the
preoperative evaluation, education of patients and families,
reduction in postoperative intensive care stay, earlier
ambulation, and earlier discontinuation of intravenous
fluid. However, surgical and anesthesia’ charges in the
postpathway group were not significantly lower than those
in the prepathway group. The reason was that no modifi-
cation of the operation and intraoperative anesthesia regi-
men was introduced during the study period. On the other
hand, this was an indication that successful implementation
of the clinical pathway for high-risk patients undergoing
elective liver resection was a multifaceted and complex
task. The multidisciplinary team and administrators
understood and supported the pathway initiative and
interdisciplinary cooperation, which was responsible for
successful implementation of the fast-track clinical path-
way [19]. In our department, we developed numerous
formal educational sessions on the fast-track clinical
pathway for every members of the multidisciplinary team
before implementation, and all elements were discussed by
the team. The team members met regularly to develop the
pathway until it was completed, and after implementation,
they continued to meet to discuss interventions so that the
pathway could be continuously improved.
Care quality improvement is a major goal in the
implementation of a fast-track clinical pathway. It is a
never-ending process; no matter how good you are, you can
always improve [20]. The members of the team provided
information that was used for mapping outcomes on the
timeline and for coordinating events to maximize effi-
ciency. Every member voiced concerns as to how the
pathway could be effectively accomplished and took an
active part in the meetings to discuss variations. The
pathway outlined specific deadlines for reaching both
educational goals and medical outcomes.
Conclusions
In the present study, we confirmed that implementation of a
fast-track clinical pathway in patients undergoing elective
liver resection could improve hepatic surgical procedures
by monitoring and improving quality of care. Reducing the
postoperative ICU stay, early oral feeding and ambulation,
earlier discontinuation of intravenous fluid, no drains or
nasogastric tubes, and early removal of urinary catheters
are effective and safe in reducing postoperative LOS and
hospital charges for high-risk patients undergoing elective
liver resection. However, in order to continuously improve
health care, the results should be monitored carefully with
repeated education and cooperation of all members of the
multidisciplinary team involved in the clinical pathway.
The study supports further development of clinical path-
ways for liver surgical procedures.
Fig. 2 Comparison of charges (in RMB) of four categories in two
groups. In 2008, 6.9 RMB were equal to $1 US (Mann–Whitney U test)
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